首页|HPV E6/E7mRNA检测与P16/Ki-67免疫组化检测对宫颈CIN2级病变的筛查价值探究

HPV E6/E7mRNA检测与P16/Ki-67免疫组化检测对宫颈CIN2级病变的筛查价值探究

扫码查看
目的:研究人乳头瘤病毒(Human papilloma virus,HPV)E6/E7mRNA与免疫组化抑癌基因P16/细胞增殖核抗原Ki-67 在宫颈上皮内瘤样病变(Cervical intraepithelial neoplasia,CIN)2 级病变筛查中的应用价值.方法:选取 2020 年 2 月至 2023 年 2 月期间本院收治的 92 例宫颈炎症及病变患者作为研究对象.根据病理检查结果,将CIN2 级患者纳入研究组(n=45),宫颈CIN1 级和宫颈炎患者纳入对照组(n=47).对比两组HPV E6/E7mRNA、P16/Ki-67 单独及联合检测阳性表达率差异,采用Logistic回归分析影响CIN2 诊断的危险因素,并采用受试者工作曲线分析 HPV E6/E7mRNA 与 P16/Ki-67 单独及联合检测在宫颈 CIN2 级病变筛查的价值.结果:研究组HPV E6/E7mRNA、P16/Ki-67单独检测阳性率、联合检测阳性率(82.22%,77.78%,84.44%)高于对照组(63.83%,48.94%,53.19%)(P<0.05).Logistic回归分析显示HPV E6/E7mRNA、P16/Ki-67 是影响CIN2 诊断的危险因素(P<0.05);HPV E6/E7mRNA、P16/Ki-67 联合检测CIN2 级病变的受试者工作特征曲线下面积为 0.688(95%CI:0.579~0.798),优于 HPV E6/E7mRNA、P16/Ki-67 单独预测[0.592(95%CI:0.476~0.708);0.634(95%CI:0.519~0.748)].联合检测的准确度、灵敏度、特异度(68.8%,84.4%,53.2%)均高于单独检测HPV E6/E7mRNA(59.2%,82.2%,36.2%)、P16/Ki-67(63.4%,77.8%,48.9%).结论:HPV E6/E7mRNA与P16/Ki-67 免疫组化检测在宫颈CIN2 级病变筛查中具有一定的应用价值,可以显著提高筛查宫颈CIN2 级病变的诊断效能.
Value of HPV E6/E7 mRNA and P16/Ki-67 Immunocytochemical Dual Staining in Screening CIN2 Lesions
Objective:To evaluate the value of human papillomavirus infection(HPV)E6/E7 mRNA and P16/Ki-67 immunocytochemical dual staining in the screening cervical intraepithelial neoplasia grade 2(CIN2)lesions.Methods:Ninety-two Patients with cervical inflammation or lesions in our hospital from February 2020 to February 2023 were enrolled,and Patients were classified into groups according to the Pathological findings.Study group(n=45)included CIN2 Patients,while control group(n=47)was consisted of CIN1 and chronic cervicitis.The Positive expression rates of HPV E6/E7 mRNA and P16/Ki-67 alone and in combination were compared between two groups.Logistic regression analysis was utilized to screen the risk factors affecting the diagnosis of CIN2 lesions,and the value of separate and combined test of HPV E6/E7mRNA and P16/Ki-67 in screening CIN2 lesions was evaluated by receiver operating characteristic(ROC)curve.Results:compared with control group,Patients in study group accounted for a larger proportion Positive for HPV E6/E7mRNA(82.22%vs 63.83%),P16/Ki-67(77.78%vs 48.94%)and E6/E7 mRNA and P16/Ki-67 dual staining(84.44%vs 53.19%),with statistical difference(all P<0.05).Logistic regression analysis suggested that HPV E6/E7mRNA and P16/Ki-67 were risk factors for CIN2 lesions(P<0.05).The area under the ROC curve of HPV E6/E7mRNA and P16/Ki-67 dual staining for detecting CIN2 lesions was 0.688(95%CI:0.579~0.798),which was larger than that of separate test of HPV E6/E7mRNA[0.592(95%CI:0.476~0.708)]and P16/Ki-67[0.634(95%CI:0.519~0.748)],with statistical difference(P<0.05).The accuracy,sensitivity and specificity of HPV E6/E7mRNA and P16/Ki-67 dual staining for detecting CIN2 lesions were 68.8%,84.4%and 53.2%,which were higher than 59.2%,82.2%and 36.2%of HPV E6/E7mRNA,and 63.4%,77.8%and 48.9%of P16/Ki-67.Conclusion:HPV E6/E7 mRNA and P16/Ki-67 immunocytochemical staining for detection of CIN2 lesions are of certain value,which can significantly improve the diagnostic efficiency of screening cervical CIN2 lesions.

HPV E6/E7 mRNAP16Ki-67CIN2 lesions

王冲、朱攀科、王雪玲

展开 >

周口永善医院病理科,河南 周口 461300

HPV E6/E7mRNA P16 Ki-67 宫颈CIN2级病变

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(6)